Home › Compare › VYYRF vs BTI

VYYRF vs BTI: Dividend Comparison 2026

VYYRF yields 2272.73% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VYYRF wins by $32854240502.57M in total portfolio value
10 years
VYYRF
VYYRF
● Live price
2272.73%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32854240502.61M
Annual income
$30,237,080,305,789,680.00
Full VYYRF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — VYYRF vs BTI

📍 VYYRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVYYRFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VYYRF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VYYRF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VYYRF
Annual income on $10K today (after 15% tax)
$193,181.82/yr
After 10yr DRIP, annual income (after tax)
$25,701,518,259,921,228.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, VYYRF beats the other by $25,701,518,259,918,860.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VYYRF + BTI for your $10,000?

VYYRF: 50%BTI: 50%
100% BTI50/50100% VYYRF
Portfolio after 10yr
$16427120251.32M
Annual income
$15,118,540,152,896,234.00/yr
Blended yield
92.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

VYYRF
No analyst data
Altman Z
-3.6
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VYYRF buys
0
BTI buys
0
No recent congressional trades found for VYYRF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVYYRFBTI
Forward yield2272.73% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$32854240502.61M ✓$37.7K
Annual income after 10y$30,237,080,305,789,680.00 ✓$2,786.64
Total dividends collected$32670211031.59M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VYYRF vs BTI ($10,000, DRIP)

YearVYYRF PortfolioVYYRF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$237,973$227,272.73$11,299$598.92+$226.7K → VYYRF
2$5,309,277$5,054,645.86$12,794$703.91+$5.30M → VYYRF
3$111,074,741$105,393,815.30$14,518$829.07+$111.06M → VYYRF
4$2,179,533,508$2,060,683,535.02$16,513$978.64+$2179.52M → VYYRF
5$40,122,002,626$37,789,901,771.73$18,827$1,157.84+$40121.98M → VYYRF
6$693,076,755,656$650,146,212,846.56$21,518$1,373.12+$693076.73M → VYYRF
7$11,237,644,552,173$10,496,052,423,620.71$24,657$1,632.46+$11237644.53M → VYYRF
8$171,075,194,313,012$159,050,914,642,187.34$28,329$1,945.74+$171075194.28M → VYYRF
9$2,445,944,109,174,152$2,262,893,651,259,228.50$32,637$2,325.33+$2445944109.14M → VYYRF
10$32,854,240,502,606,024$30,237,080,305,789,680.00$37,708$2,786.64+$32854240502.57M → VYYRF

VYYRF vs BTI: Complete Analysis 2026

VYYRF — Stock

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Full VYYRF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this VYYRF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VYYRF vs SCHDVYYRF vs JEPIVYYRF vs OVYYRF vs KOVYYRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.